About
Sirtex Medical Limited is a global medical device company based in Australia, founded in 1997. The company specializes in targeted radioactive treatment for inoperable liver cancer. Its flagship product, SIR-Spheres Y-90 resin microspheres, is used in Selective Internal Radiation Therapy (SIRT). These tiny radioactive beads are injected directly into liver tumors, allowing for a highly targeted radiation dose while minimizing damage to healthy tissue. Sirtex operates offices and manufacturing facilities in the United States, Australia, Germany, and Singapore. The company has supplied over 100,000 doses of its treatment worldwide, with applications in more than 1,300 medical centers across over 50 countries. Sirtex collaborates with other healthcare technology companies to enhance personalized dosimetry and support multidisciplinary treatment approaches, aiming to improve patient outcomes globally.
Technologies
Keywords
Company Information
-
Employees 330
-
Founded 1997
-
Annual Revenue $110000000
Location
300 Unicorn Park Drive, Woburn, Massachusetts, United States, 01801